Titel

Merkliste
1 Ergebnisse

Discovery and Optimization of Orally Bioavailable Phthalazo..:

Oscar Mammoliti (1923286) ; Koen Jansen (1822096) ; Sandy El Bkassiny (10740138)...
https://figshare.com/articles/dataset/Discovery_and_Optimization_of_Orally_Bioavailable_Phthalazone_and_Cinnolone_Carboxylic_Acid_Derivatives_as_S1P2_Antagonists_against_Fibrotic_Diseases/16692349. , 2021

Link: https://doi.org/10.1021/acs.jmedchem.1c01066.s004

RT Journal
T1 <Title>Discovery and Optimization of Orally Bioavailable Phthalazone and Cinnolone Carboxylic Acid Derivatives as S1P2 Antagonists against Fibrotic Diseases</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftsmithonian:oai:figshare.com:article_16692349&Exemplar=1&LAN=DE
				
A1 Oscar Mammoliti (1923286)
A1 Koen Jansen (1822096)
A1 Sandy El Bkassiny (10740138)
A1 Adeline Palisse (10740135)
A1 Nicolas Triballeau (1400671)
A1 Denis Bucher (352807)
A1 Brigitte Allart (2944395)
A1 Alex Jaunet (1863439)
A1 Giovanni Tricarico (9941678)
A1 Maxim De Wachter (11494630)
A1 Christel Menet (9941675)
A1 Javier Blanc (1714399)
A1 Vatroslav Letfus (11494633)
A1 Renata Rupčić (2115004)
A1 Mario Šmehil (11494636)
A1 Tanja Poljak (11494639)
A1 Beatrice Coornaert (10740141)
A1 Kathleen Sonck (5898149)
A1 Inge Duys (10740144)
A1 Ludovic Waeckel (11494642)
A1 Lola Lecru (332155)
A1 Florence Marsais (11494645)
A1 Catherine Jagerschmidt (753692)
A1 Marielle Auberval (3989720)
A1 Philippe Pujuguet (11494648)
A1 Line Oste (1705675)
A1 Monica Borgonovi (4747311)
A1 Emanuelle Wakselman (1705648)
A1 Thierry Christophe (242276)
A1 Nicolas Houvenaghel (10740147)
A1 Mia Jans (4376776)
A1 Bertrand Heckmann (632958)
A1 Laurent Sanière (10740150)
A1 Reginald Brys (1705672)
YR 2021
K1 Biochemistry
K1 Medicine
K1 Pharmacology
K1 Biotechnology
K1 Ecology
K1 Cancer
K1 Biological Sciences not elsewhere classified
K1 Chemical Sciences not elsewhere classified
K1 potent phthalazone series
K1 orally bioavailable phthalazone
K1 increasing evidence suggests
K1 chemical enablement strategy
K1 progressive lung disease
K1 s1p2 antagonists could
K1 6 </ b
K1 s1p2 antagonists
K1 disease progression
K1 vivo </
K1 vitro </
K1 s1p2 activity
K1 three different
K1 therapeutic setting
K1 suboptimal pharmacokinetics
K1 scaffold hopping
K1 rapid exploration
K1 position adjacent
K1 mouse models
K1 kg bid
K1 homology model
K1 good pharmacokinetics
K1 fibrotic diseases
K1 effective agents
K1 eccs )
K1 current treatments
K1 concepts deriving
K1 carboxylic acid
K1 benzimidazole subseries
K1 10 mg
JF https://figshare.com/articles/dataset/Discovery_and_Optimization_of_Orally_Bioavailable_Phthalazone_and_Cinnolone_Carboxylic_Acid_Derivatives_as_S1P2_Antagonists_against_Fibrotic_Diseases/16692349
LK http://dx.doi.org/https://doi.org/10.1021/acs.jmedchem.1c01066.s004
DO https://doi.org/10.1021/acs.jmedchem.1c01066.s004
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)